Thrombotic Risk Determined by STAB 2 Variants in a Population-Based Cohort Study.
暂无分享，去创建一个
Alexander E. Lopez | Andrew L Blumenfeld | G. Abecasis | S. Balasubramanian | A. Hawes | K. Siminovitch | O. Melander | L. Mitnaul | L. Habegger | G. Engström | A. Shuldiner | W. Salerno | J. Overton | N. Verweij | C. Halldén | A. Baras | J. Staples | S. O’Keeffe | K. Karalis | L. Lotta | P. Svensson | O. Krasheninina | Bengt Zöller | C. Lind‐Halldén | J. Elf | E. Manderstedt | S. Khalid | X. Bai | Christina Beechert | Gisu Eom | Caitlin Forsythe | Erin D. Fuller | Zhenhua Gu | Michael Lattari | Kia Manoochehri | E. Maxwell | Manasi Pradhan | T. Schleicher | Ricardo Ulloa | Louis Widom | Sarah E. Wolf | A. Mansfield | Jason Mighty | T. De | R. Lanche | G. Coppola | J. Reid | R. Panea | Marcus Jones | A. Rasool | M. LeBlanc | M. Cantor | Boris Boutkov | Max Orelus | Tommy Polanco | Jonas B. Nielsen | Mrunali Nafde | Maria Sotiropoulos Padilla | C. Forsythe
[1] D. Goldstein,et al. Whole exome sequencing identifies rare variants in STAB2 associated with venous thromboembolic disease. , 2020, Blood.
[2] O. Melander,et al. Factor V Leiden paradox in a middle-aged Swedish population: A prospective study , 2018, Vascular medicine.
[3] J. Ludvigsson,et al. External review and validation of the Swedish national inpatient register , 2011, BMC public health.
[4] M. Pencina,et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. , 2009, JAMA.
[5] L. Wilhelmsen,et al. Psychosocial factors and venous thromboembolism: a long‐term follow‐up study of Swedish men , 2008, Journal of thrombosis and haemostasis : JTH.